Marie‐Pierre Préziosi

Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results

Hongchao Pan, Richard Peto, Quarraisha Abdool Karim et al. · medRxiv · 2020 · 635 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal

François Simondon, Marie‐Pierre Préziosi, Ablaye Yam et al. · Vaccine · 1997 · 267 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

Impact of MenAfriVac in nine countries of the African meningitis belt, 2010–15: an analysis of surveillance data

Caroline Trotter, Clément Lingani, Katya C. Fernandez et al. · The Lancet Infectious Diseases · 2017 · 232 citations · Full text

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +14

Impact of the Serogroup A Meningococcal Conjugate Vaccine, MenAfriVac, on Carriage and Herd Immunity

Paul A. Kristiansen, Fabien Diomandé, Absatou Ky Ba et al. · Clinical Infectious Diseases · 2012 · 211 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in Africans

Samba O. Sow, Brown J. Okoko, Aldiouma Diallo et al. · New England Journal of Medicine · 2011 · 174 citations · Full text

Veterinary Medicine, Immunology, Pediatrics +17